ONCY - Oncolytics Biotech - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

ONCY is currently covered by 2 analysts with an average price target of $4.12. This is a potential upside of $3.06 (288.68%) from yesterday's end of day stock price of $1.06.

Oncolytics Biotech's activity chart (see below) currently has 3 price targets and 10 ratings on display. The stock rating distribution of ONCY is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ONCY is $5, Lowest price target is $5, average price target is $4.12.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 14-Feb-2024. First documented stock forecast 17-Feb-2021.

Best performing analysts who are covering ONCY - Oncolytics Biotech:

John Newman Patrick Trucchio

Currently out of the existing stock ratings of ONCY, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$3.84 (331.03%)

5

2 months 2 days ago

0/5 (0%)

$3.85 (334.78%)

Buy

5

$3.84 (331.03%)

5

9 months 24 days ago

0/3 (0%)

$2.26 (82.48%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCY (Oncolytics Biotech) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ONCY (Oncolytics Biotech) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on ONCY (Oncolytics Biotech) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on ONCY (Oncolytics Biotech)?

John Newman works at CANACCORD and has 3 price targets and 3 ratings on ONCY

Which analyst is the currently most bullish on ONCY (Oncolytics Biotech)?

Patrick Trucchio with highest potential upside - $3.84

Which analyst is the currently most reserved on ONCY (Oncolytics Biotech)?

John Newman with lowest potential downside - $3.84

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?